Industry Overview:

The latest report by IMARC Group, titled “Biodefense Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the biodefense market size. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global biodefense market size reached US$ 15.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.32% during 2023-2028.

Biodefense includes the utilization of several medical and military measures that are taken to safeguard individuals against bioterrorism. Bioterrorism refers to the usage of biological toxins or infectious agents that can be used with the intent to kill or infect humans and instigate biological warfare. It involves using several living organisms, such as bacteria, viruses, fungi, and toxins, that can result in causing chronic illnesses among animals and humans while acting as a threat to the environment as well. Numerous interventions, including drugs and vaccinations, can help counter the acts of bioterrorism by limiting the spread of the disease. Apart from this, conducting research and specific public health procedures can also aid in protecting individuals against biological threats and providing necessary medical care to the affected.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/biodefense-market/requestsample

Global Biodefense Market Trends:

The global market is primarily driven by the growing awareness regarding bioterrorism, along with the increasing tensions between several nations. This has encouraged the governments of these countries to expand their defense budgets and invest in biodefense in an attempt to equip the public healthcare system with an efficient disease surveillance system that takes rapid actions to counter biological threats. Additionally, they are undertaking initiatives to increase the funding for procuring, developing and utilizing advanced medical countermeasures against biological, chemical, radiological, and nuclear (CBRN) warfare agents.

Moreover, continual technological advancements in the field of genetic engineering and biotechnology are creating a positive outlook for the market. Numerous players are also leveraging these advanced technologies to launch innovative biothreat detection devices that assist in the identification of several viruses and bacteria in an efficient manner. The market is further driven by the escalating need for effective medical measures and threat detection procedures on account of the rapid outbreak of the COVID-19 pandemic.

Global Biodefense Market 2023- 2028 Analysis and Segmentation:

Competitive Landscape with Key Players:

Achaogen Inc.
Alnylam Pharmaceuticals Inc.
Altimune Inc. (PharmAthene Inc.)
Bavarian Nordic A/S
Cleveland BioLabs Inc.
Dynavax Technologies Corporation
Dynport Vaccine Company LLC (General Dynamics Corporation)
Elusys Therapeutics Inc.
Emergent Biosolutions Inc.,
Ichor Medical Systems Inc.
Ology Bioservices Inc.
SIGA Technologies, Inc

Key Market Segmentation:

Vaccine Type:

Anthrax
Smallpox
Botulism
Others

Biothreat Detection Device:

Samplers
Detectors/Triggering Devices
Identifiers
Assays
Others

End-User:

Hospitals and Clinics
Ambulatory Care Centers
Others

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Billion
Segment Coverage	Vaccine Type, Biothreat Detection Device, End-User, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Achaogen Inc., Alnylam Pharmaceuticals Inc., Altimmune Inc. (PharmAthene Inc.), Bavarian Nordic A/S, Cleveland BioLabs Inc., Dynavax Technologies Corporation, Dynport Vaccine Company LLC (General Dynamics Corporation), Elusys Therapeutics Inc., Emergent Biosolutions Inc., Ichor Medical Systems Inc., Ology Bioservices Inc. and SIGA Technologies, Inc.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

1. What was the size of the global biodefense market in 2022?

2. What is the expected growth rate of the global biodefense market during 2023-2028?

3. What are the key factors driving the global biodefense market?

4. What has been the impact of COVID-19 on the global biodefense market?

5. What is the breakup of the global biodefense market based on the vaccine type?

6. What is the breakup of the global biodefense market based on the end-user?

7. What are the key regions in the global biodefense market?

8. Who are the key players/ companies in the global biodefense market?

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800